Private Equity
1 min read · 22 July 2010
2 min read · 22 July 2010
Flipboard, a social magazine designed for the iPad, has raised $10.5 million from Kleiner Perkins Caufield & Byers and Index Ventures. Part of the proceeds were used to acquire real-time Web intelligence company Ellerdale.
3 min read · 21 July 2010
Gazelle, a Boston-based "re-commerce" startup, has raised $12 million in Series C funding. Physic Ventures led the round, and was joined by return backers Venrock and RockPort Capital Partners.
4 min read · 21 July 2010
Calient Technologies Inc., a Santa Barbara, Calif.-based provider of photonic switching solutions, has raised $10 million in new funding. It also named Arjun Gupta, founder of TeleSoft Partners and an existing Calient shareholder, as chairman.
3 min read · 21 July 2010
Actelion Ltd. has paid €10 million for an option to acquire Trophos SA, a Marseille, France-based drug company focused on neurological disorders. The purchase price would be between €125 and €195 million. Trophos has raised VC funding from OTC Asset Management, CM-CIC Capital Prive, SGAM, Viveris Management, Turenne Capital Partners, Blue Medical and the Association Francaise contre les Myopathies.
3 min read · 21 July 2010
Eli Lilly & Co. has completed its acquisition of Alnara Therapeutics Inc., a Cambridge, Mass.-based developer of orally-delivered protein therapeutics for the treatment of metabolic diseases. The deal is worth upwards of $380 million, including a $180 million up-ffront payment. Alnara had raised $55 million from MPM Capital, Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners.
2 min read · 21 July 2010
Trada, a Boulder, Colo.-based startup focused on the paid search optimization space, has raised $5.75 million in Series C funding. Google Ventures led the round, and was joined by return backer Foundry Group. The company previously raised $2.2 million.
4 min read · 21 July 2010
Movitas, a Philadelphia-based provider of hospitality-focused mobile solutions, has raised $3 million in VC funding from undisclosed investors.
2 min read · 21 July 2010
Cara Therapeutics Inc., a Tarrytown, N.Y.-based biotech company focused on pain and inflammation, has raised $15 million in Series D funding. Rho Ventures led the round, and was joined by return backers Alta Biopharma, Ascent Biomedical Ventures, CT Innovations, Devon Park BioVentures, Healthcare Private Equity, Mitsubishi International Corporation and MVM Life Science Partners. The company previously raised $36.3 million.
3 min read · 21 July 2010
